Free Trial

Clene (CLNNW) Competitors

$0.03 0.00 (0.00%)
As of 07/25/2025 11:58 AM Eastern

CLNNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Clene stock or one of its competitors? The main competitors of Clene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Clene vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Clene (NASDAQ:CLNNW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 equaled Clene'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Very Positive
Clene Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Clene$350KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Clene N/A N/A N/A

Summary

Clene beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLNNW vs. The Competition

MetricCleneBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$136.77M$5.70B$9.50B
Dividend YieldN/A3.74%4.58%4.00%
P/E RatioN/A3.7828.3920.08
Price / SalesN/A4,471.55431.7788.79
Price / CashN/A13.1936.2258.56
Price / BookN/A42.328.675.88
Net IncomeN/A-$90.99M$3.25B$258.89M
7 Day PerformanceN/A4.86%4.30%3.71%
1 Month PerformanceN/A8.36%10.57%11.72%
1 Year PerformanceN/A195.82%35.68%18.00%

Clene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLNNW
Clene
N/A$0.03
flat
N/A+14.1%$0.00$350K0.00100Positive News
ATNFW
180 Life Sciences
N/A$0.01
-1.2%
N/A+22.2%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
-63.4%
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.12
+2.2%
N/A+95.0%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.65
-7.3%
N/A-0.7%$0.00$585.60M0.004Gap Down
AMPE
Ampio Pharmaceuticals
N/AN/AN/A+154.5%$0.00N/A0.0020Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+75.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+21.5%
N/AN/A$0.00$38.00M0.0070Positive News
BTMDW
biote
N/A$0.01
-3.4%
N/A-96.8%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.05
-29.9%
N/A-78.1%$0.00N/A0.008Gap Up

Related Companies and Tools


This page (NASDAQ:CLNNW) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners